Browse by Poster Presenter

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

B
Babalola, Kabirat

University of Alabama
(M1330-01-04) The Non-GLP Dose Range-Finding Study on Lymphatic-Targeting of Cyclosporine in Mrl-lpr Mouse Model of SLE
Kabirat Babalola
Favorite
(T1530-04-19) Lymphatic Targeting of Cyclosporine Improves Survival and Ameliorates Lupus-Like Autoimmune Disease in NZB/W Mice
Kabirat Babalola
Favorite
Babu, Milan

Patheon, part of Thermo Fisher Scientific
(M1230-07-40) Optimization of Excipients Attributes of Immediate Release Tablet Formulation Using Quality by Design
Milan Babu
Favorite
Babu, R. Jayachandra

Auburn University
(M0930-05-26) Advancing the Use of Chimeric Antigen Receptor T-cell Therapy (CAR T) in Glioblastoma Treatment
R. Jayachandra Babu
Favorite
(M1130-09-52) Inclusion Complexes of Posaconazole with Hydroxypropyl- and Sulfobutylether-β-Cyclodextrins for Intravenous Injections: Formulation and Stability Studies
R. Jayachandra Babu
Favorite
(T0930-03-13) Comprehensive Study on Injectable Capsaicin In Situ Forming Implant for Ultra-Long-Acting Anti-Obesity: Formulation, Characterization, Drug Release, Stability, and Cytotoxicity Studies
R. Jayachandra Babu
Favorite
(T1330-05-27) Co-delivery of Curcumin and Sildenafil Citrate with 3D-Printed Collagen-Chitosan Scaffolds for Enhanced Wound Healing
R. Jayachandra Babu
Favorite
(T1530-03-17) Advancing Cancer Immunotherapy: Real-Time Immune Profiling and Cytokine Monitoring with an Integrated Biosensing Platform
R. Jayachandra Babu
Favorite
Badger, Sydney

Colorcon, Inc.
(M1530-01-05) Evaluation of a TiO2-Free PVA-Based Film Coating System with Improved Opacity and Color Uniformity
Sydney Badger
Favorite
Badola, Muskan

University of Minnesota
(W1030-07-38) Development of Targeted Nanovehicles to Deliver Biomolecules to Cerebrovascular Endothelium
Muskan Badola
Favorite
Badruddoza, Abu Zayed

Pfizer Inc.
(W1130-07-38) Sustainable Alternatives to Petroleum-Derived Excipients in Topical Creams
Abu Zayed Badruddoza
Favorite
Baek, Eun Jin

Ajou University
(M1130-03-15) Utilization of Gelatin-Oleic Acid Conjugate Solid Dispersion for Enhanced Stability of Water-Labile Drug
Eun Jin Baek
Favorite
(M1230-01-02) Redox-Responsive Fattigated Nanoparticles Potentiate Lipid Accumulation and Controlled Doxorubicin Release for Boosting the Anti-Cancer Activity
Eun Jin Baek
Favorite
(M1330-01-02) Enhanced Permeability and Stability of Self-Assembled Fatty Acid-Conjugated Peptide Drug Nanoparticles for Oral Delivery
Eun Jin Baek
Favorite
(M1330-03-15) Thermal Stability and Controlled Release of Fattigated Vaccine Antigen in Human Serum Albumin Nanoparticle
Eun Jin Baek
Favorite
(M1430-03-15) Physicochemical Properties and Controlled Peptide Drug Release via Hydrophobicity Modulation of Albumin-Oleic Acid Conjugate
Eun Jin Baek
Favorite
(T1530-07-40) Design and Enhanced Permeability of Sublingual Tablets Containing Leuprolide Nanoparticles With or Without Permeation Enhancers
Eun Jin Baek
Favorite
Bae, Sung Hun

Binghamton University
(M1430-02-09) A PBPK Model for Prediction of Apixaban and Rivaroxaban Secretion into Milk
Sung Hun Bae
Favorite
Bagde, Arvind

Florida A&M University
(T0930-11-63) Solid-State NMR and FTIR Reveal Moisture-Triggered Adhesion Loss in Rotigotine Patches
Arvind Bagde
Favorite
(T1130-02-11) Cannabinoid Combination Therapy for Doxorubicin Resistant MDA-MB231: Oral Exosome Formulation Versus Parenteral Approaches
Arvind Bagde
Favorite
(W0930-11-63) Improving Adhesion Evaluation of Transdermal Rotigotine Patches: Utilizing Skin-Mimicking Substrates for Accurate Assessment
Arvind Bagde
Favorite
Bagde, Shapali

US Food and Drug Administration
(W1230-07-38) Ethanol Solubility of Rate Controlling Polymer in Modified Release Formulation Can Impact Alcohol Dose Dumping: An Assessment Through Principal Component Analysis
Shapali Bagde
Favorite
Baghla, Rahul

SCIEX
(T1130-04-24) Automated Workflow for Targeted Protein Degrader (TPD) Metabolite Identification Using Collision-Induced Dissociation (CID) and Electron-Activated Dissociation (EAD)
Rahul Baghla
Favorite
Bagwe, Priyal

US Food and Drug Administration
(M1130-03-17) Enhancing Gonorrhea Vaccine Efficacy: Dosage Response Analysis of a Novel Microparticulate Formulation
Priyal Bagwe
Favorite
(M1130-06-36) A Cell-To-Cell Contact Immune System Mimicking In Vitro Overlay Assay: Evaluating Nanoparticle Vaccine Formulations for Adaptive Immunity Responses
Priyal Bagwe
Favorite
Bahamondez, Tania

Universidad de Valparaiso
(M1230-09-50) The Hidden Potential: Enhancing Doxycycline Dissolution and Aerodynamics with HPMC and Gelatin for Pulmonary Drug Delivery
Tania Bahamondez
Favorite
Baisa, Srikanth

University of Mississippi
(M0930-09-49) Formulation Development of Simvastatin Self-Emulsifying Drug Delivery System Using Hot Melt Extrusion
Srikanth Baisa
Favorite
Baker, Manasi

Secant Group
(M1130-09-49) Controlled Release of Proteins with Hydralese^® Formulations for Long-Acting Implants
Manasi Baker
Favorite
(T1530-07-41) A Tunable, Biodegradable Drug Delivery Platform with Hydralese^TM for Long-Acting Implants
Manasi Baker
Favorite
Baldizar, Christie

Anton Paar USA, Inc.
(M0930-11-64) Low Surface Area Measurements of Excipients, Replacing Krypton with Nitrogen
Christie Baldizar
Favorite
Baliu-Rodriguez, David

Lawrence Livermore National Laboratory
(M0930-06-31) Parallel Accelerator and Molecular Mass Spectrometry for Tracing ¹⁴C-Labeled Metabolites
David Baliu-Rodriguez
Favorite
(T1130-11-63) Optical Radiocarbon (¹⁴C) Tracing for Biological and Pharmaceutical Applications
David Baliu-Rodriguez
Favorite
Ballantyne, Joanne

Waters Corporation
(T1230-04-19) Novel Targeted Drug and Metabolites Mapping Using DESI MRM Triple Quadrupole Mass Spectrometer Providing Increased Sensitivity and Acquisition Speed for Mass Spectrometry Imaging
Joanne Ballantyne
Favorite
Balmert, Stephen

University of Pittsburgh
(M1230-06-31) Manipulating the PLGA Terminal Group Chemistry Alters Electrostatic Controlled Release from Polymeric Microparticles
Stephen Balmert
Favorite
(M1230-07-37) Local Controlled Delivery of an A3 Receptor Agonist Reduces Inflammation Associated with Contact Hypersensitivity
Stephen Balmert
Favorite
(T1230-11-60) Characterizing the Effect of Critical Processing Parameters on Critical Quality Attributes of Protein-Loaded Double Emulsion Microparticles
Stephen Balmert
Favorite
Baltrip, Emanuel

University of Houston
(T1030-06-35) A Validated LC-MS/MS Assay for the Simultaneous Determination of Nebivolol, Dasatinib and Devimistat and Its Application to Pharmacokinetic Study in Rats
Emanuel Baltrip
Favorite
Balu-iyer, Sathy

University at Buffalo
(W0930-02-12) Oral Tolerance Mediated by Phosphatidylserine Containing Lipid Nanoparticle
Sathy Balu-iyer
Favorite
Bambarkar, Sunil

Gattefosse India Pvt., Ltd.
(T1130-01-05) Platform Technology for Introducing Liquid Solubilisers in Tablet Formulations
Sunil Bambarkar
Favorite
Banach, Grzegorz

Physiolution Polska sp. z o. o.
(M0930-02-09) Predicting Bioequivalence with the COMPASS Tool - Analysis of the Experimental and Literature Data
Grzegorz Banach
Favorite
Banda, Brenda Natalia

University of North Texas Health Science Center
(M1130-05-26) Effect of Tumor Grade and Type on ECM-Liposome Interactions Measured by Contact Angle
Brenda Natalia Banda
Favorite
Bande, Divya

Virginia Commonwealth University
(M1130-07-37) Inflammatory Response to Lipopolysaccharide-Induced Injury and Treatment with Extracellular Matrix-Derived Nanoparticles
Divya Bande
Favorite
Banella, Sabrina

University of Ferrara
(M1330-01-06) Formulation of a Poorly Soluble Antiviral Drug as Microparticle Powder for Nasal Breath Intake Against Respiratory Infections
Sabrina Banella
Favorite
Banerjee, Anurag

North Dakota State University
(M1330-03-14) Mesenchymal Stem Cell-Based Drug Delivery Approach for Effective Management of Pancreatic Cancer
Anurag Banerjee
Favorite
(W1030-07-39) Mesenchymal Stem Cell-Based Combination Therapy for Enhanced Efficacy Against Patient-Derived Lung Cancer Xenograft Model
Anurag Banerjee
Favorite
Banga, Ajay

Mercer University
(M1030-01-04) Development of Extrusion-Based 3D Printed Hydrophilic Polymeric Transdermal Films of Pramipexole Dihydrochloride for Parkinson’s disease
Ajay Banga
Favorite
(M1030-03-16) Development and Characterization of PLGA Tip-Loaded Polymeric Microneedles for the Sustained, Week-Long Release of a Lipophilic Molecule-Carfilzomib
Ajay Banga
Favorite
(M1030-05-28) In Vitro and In Vivo Evaluation of Topical 4-phenylbutyric Acid Microsponge Formulation as a Potential Antidote Against Arsenical-Induced Skin Injury
Ajay Banga
Favorite
(M1230-01-04) Week-Long Transdermal Delivery of an Anxiolytic Drug Using Tip-Loaded PVA Microneedles
Ajay Banga
Favorite
(M1230-03-16) Enhanced Skin and Follicular Delivery of Tazarotene from PLGA Nanoparticles for the Treatment of Acne and Psoriasis
Ajay Banga
Favorite
(M1430-01-05) Formulation and Skin Delivery of Quercetin Loaded PAMAM Dendrimer-Based Gel for Potential Anti-Inflammatory and Antioxidant Effect
Ajay Banga
Favorite
(M1530-07-41) Preparation and Characterization of Hydrogel Microneedles Using Gantrez®S-97 and Hyaluronic Acid
Ajay Banga
Favorite
(T1130-06-34) In Vitro Topical and Transdermal Delivery of 4-Phenylbutyric Acid Emulsome Loaded Foam Formulation for the Treatment of Chemical Warfare Agent-Induced Skin Injury
Ajay Banga
Favorite
(T1330-01-02) Topical and Transdermal Delivery of 4-phenyl-butyric Acid Through Chitosan Nanoparticles Dispersed in a Foam Formulation: A Potential Antidote for Skin Injury Due to Chemical Warfare Agents
Ajay Banga
Favorite
(T1430-01-04) Exploration of Antioxidant Activity and Conversion Potential of Cosmeceutical Actives: Ascorbic Acid and Its Derivatives
Ajay Banga
Favorite
(W1030-05-26) Transdermal Lamivudine Deep Eutectic Systems for the Long-Term Management of Pediatric Hepatitis B Virus and HIV Infections
Ajay Banga
Favorite
(W1030-05-29) Topical Cream Formulation of Integrated Stress Response Inhibitor (ISRIB) for the Potential Treatment of Chemical Warfare Skin Injury: Effect of Chemical Enhancers, Concentration, and pH
Ajay Banga
Favorite
(W1230-01-05) Vacuum Compression Molding: A Novel Method to Fabricate Drug-Loaded Microneedles for Three-Day Transdermal Delivery of Palonosetron Hydrochloride
Ajay Banga
Favorite
Bankali, Amrutharaj

Intera Healthcare
(M1130-03-14) Development and Characterization of Preservative Free Ocular Formulation
Amrutharaj Bankali
Favorite
Bano, Nazneen

Merck & Co., Inc.
(M1030-06-31) Utilizing LC-MS to Support of PABAD-Based Detection of Neutralizing Antibodies
Nazneen Bano
Favorite
Bao, Qing

University of Illinois Chicago
(M1330-07-37) Immunoactive Nanoparticle Boosted cDC1 for In Situ Cancer Immunotherapy
Qing Bao
Favorite
Bao, Quanying

Alexion Pharmaceuticals, Inc.
(M1130-04-20) Impact of Macrophages on the Dissolution of Long-Acting Injectable Suspensions
Quanying Bao
Favorite
Bao, Wei

ICE Bioscience
(M1030-04-19) Integrated Screening Platform of PDE for Lung Fibrosis Drug Discovery
Wei Bao
Favorite
Barbas, Rafael

University of Barcelona
(T0930-09-52) Biphasic Dissolution Rate and Absorption Study of Adefovir Dipivoxil and Its Cocrystals under Biorelevant Conditions
Rafael Barbas
Favorite
Barbour, Tara

Apellis Pharmaceuticals
(W0930-02-08) Lumbar Intrathecal Infusion of an siRNA Formulation via Cannulation in Rats Demonstrated Comparable Tissue Distributions and Improved Animal Response as Comparing to Non-Cannulated Free Hand Method
Tara Barbour
Favorite
Barhydt, Tracy

Dow Development Laboratories, LLC
(W1030-07-40) Using Gravitational Force to Determine the Minimum Concentration of Various Gelling Agents Needed to Maintain Homogeneity of Micronized API in Suspension
Tracy Barhydt
Favorite
Barnes, Jeffrey

ARx, LLC
(T1030-09-52) Weekly Apixaban Transdermal Delivery System
Jeffrey Barnes
Favorite
(T1130-09-52) A Modelling and Simulation Assessment of Steady State Apixaban Delivered from a Weekly Transdermal Patch
Jeffrey Barnes
Favorite
Barnhart, Scott

ARx, LLC
(T1030-09-52) Weekly Apixaban Transdermal Delivery System
Scott Barnhart
Favorite
(T1130-09-52) A Modelling and Simulation Assessment of Steady State Apixaban Delivered from a Weekly Transdermal Patch
Scott Barnhart
Favorite
Barros, Caio

NIBRT
(W1230-11-65) Effect of Lyophilization Process Parameters on the Stability of mRNA Lipid Nanoparticles (LNP)
Caio Barros
Favorite
Barry, Jessica

University of Minnesota
(T1530-02-11) Prediction of Lacosamide Concentrations to Optimize Dosing during Pregnancy
Jessica Barry
Favorite
Bartlett, Amy

Waters Corporation
(M1430-05-26) Rapid and Reliable Nitrite Content Analysis in Pharmaceutical Excipients with the ACQUITY^TM QDa^TM II Mass Detector
Amy Bartlett
Favorite
Basarkar, Ashwin

Bristol-Myers Squibb Company
(W1130-07-37) Drug Product Development Approaches to Overcome Stability Challenges of Antibody Drug Conjugates (ADCs)
Ashwin Basarkar
Favorite
Bashar, Mohamed

Binghamton University
(M1430-02-09) A PBPK Model for Prediction of Apixaban and Rivaroxaban Secretion into Milk
Mohamed Bashar
Favorite
Bashetty, Sujith Raj

University of Mississippi
(M1030-09-49) Selective Laser Sintering 3D Printing for Improved Solubility of Indomethacin: A Study on Amorphous Drug Conversion
Sujith Raj Bashetty
Favorite
(T1130-07-41) Novel 3D Printed Polypill for Diabetes Mellitus Management and Associated Cardiovascular Risks
Sujith Raj Bashetty
Favorite
(T1330-09-50) Exploratory Studies of Curcumin Loaded PCL Microparticles Produced Using a Novel Technology- SMART
Sujith raj Bashetty
Favorite
Basim, Pratap

Thermo Fisher Scientific
(M0930-01-03) Overcoming Direct Compression Issues in Omeprazole Formulations Using Co-Processed Excipient vs. Wet Granulation
Pratap Basim
Favorite
(W1230-10-56) Efficient Manufacturing of Omeprazole Modified-Release Minitablets Using “All-in-One” Co-Processed Excipient and Talc-Free Aqueous Coating System
Pratap Basim
Favorite
Basit, Abdul

University College London
(M1330-09-52) Non-Destructive Quality Control of Medicines Produced through 3D Printing in a Hospital Using Two Handheld Spectrometers
Abdul Basit
Favorite
(T1130-09-48) Rapid Production of Personalized Breast Cancer Medicines for Inclusion in a Clinical Trial Using a Novel Pharmaceutical 3D Printing Platform in a Hospital
Abdul Basit
Favorite
Baskaran, Padmamalini

Howard University
(T0930-03-13) Comprehensive Study on Injectable Capsaicin In Situ Forming Implant for Ultra-Long-Acting Anti-Obesity: Formulation, Characterization, Drug Release, Stability, and Cytotoxicity Studies
Padmamalini Baskaran
Favorite
Bataille Backer, Perpetue

Howard University
(W1030-05-25) Targeted Peptide Dual Drug Conjugate for the Treatment of Glioblastoma
Perpetue Bataille Backer
Favorite
Baudelet, Margot

Ghent University Hospital
(T1330-07-41) Toward High Drug-Loaded Pellets to Overcome Dysphagia: Safety and Acceptability of Placebo Pellets Co-Administered with a Swallowing Gel in Healthy Volunteers
Margot Baudelet
Favorite
Baumann, Michael

International Flavors and Fragrances
(T1030-01-01) Vegetarian Softgels Using SeaGel® Technology for Pharmaceutical Applications
Michael Baumann
Favorite
Baumhof, Patrick

CureVac
(T1030-10-57) Dry Powders of a Rabies G Protein mRNA Vaccine Candidate Prepared by Thin-Film Freeze-Drying
Patrick Baumhof
Favorite
Bauser, Haley

Varda Space Industries
(M1230-11-62) Physical Stability of Ritonavir Crystallized in Space
Haley Bauser
Favorite
(T1230-11-62) Chemical Stability of Ritonavir Crystallized in Space
Haley Bauser
Favorite
(W1030-11-61) Sending Ritonavir to Space and Back – Drug Development Enabled by Specially Designed Hardware to Perform in Microgravity
Haley Bauser
Favorite
Bayne, Anne-Cecile

dsm-firmenich
(M1430-04-19) Discovery of BB99: A Potent T2R54 (TAS2R39) Antagonist that Blocks the Bitterness of Select Active Pharmaceutical Ingredients (APIs)
Anne-Cecile Bayne
Favorite
(W0930-03-14) A Journey Through the Development of Cannabidiol Solid Oral Dosage Forms: Balancing API Loading, Physico-Chemical Stability and In Vivo Pharmacokinetic Performance
Anne-Cecile Bayne
Favorite
Baynham, Michael

Waters Corporation
(M1430-11-63) Going Greener with the USP 621 Globally Harmonized Pharmacopeial Guidance for Liquid Chromatography
Michael Baynham
Favorite
Bayoumy, Shariff

Mebias Discovery, Inc.
(T1230-02-11) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Rats in a 28-Day Oral Toxicity Study
Shariff Bayoumy
Favorite
(W0930-02-09) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Dogs in a 28-Day Oral Toxicity Study
Shariff Bayoumy
Favorite
Becker, Carly

Huntsman Cancer Institute
(W0930-01-02) Transdermal Delivery of Ultradeformable Cationic Liposomes Complexed with microRNA Prevents Transformation of Melanocytes to Melanoma
Carly Becker
Favorite
Bedogni, Giselle

Universidad Nacional de Rosario
(M1530-09-50) Exploring Manufacturing Techniques for Enhancing the Solubility of Fenbendazole: A Comparative Study of Hot-Melt Extrusion, Spray Drying, and KinetiSol® Processing
Giselle Bedogni
Favorite
Begley, Ben

Aliri Bioanalysis
(M1130-06-33) A Derivatization-Free LCMS Assay for 4β-Hydroxycholesterol
Ben Begley
Favorite
(M1430-06-34) Validated Biomarker Assay for the Analysis of Coproporphyrin I and Coproporphyrin III in Human Plasma
Ben Begley
Favorite
Begley, John

Aliri Bioanalysis
(M1130-06-33) A Derivatization-Free LCMS Assay for 4β-Hydroxycholesterol
John Begley
Favorite
(M1430-06-34) Validated Biomarker Assay for the Analysis of Coproporphyrin I and Coproporphyrin III in Human Plasma
John Begley
Favorite
Begley, Matthew

Aliri Bioanalysis
(M1430-06-34) Validated Biomarker Assay for the Analysis of Coproporphyrin I and Coproporphyrin III in Human Plasma
Matthew Begley
Favorite
Behrend-Keim, Beatriz

University of Texas at Austin
(M1530-09-50) Exploring Manufacturing Techniques for Enhancing the Solubility of Fenbendazole: A Comparative Study of Hot-Melt Extrusion, Spray Drying, and KinetiSol® Processing
Beatriz Behrend-Keim
Favorite
Behrs, Jonathan

Dow Development Laboratories, LLC
(W1030-07-40) Using Gravitational Force to Determine the Minimum Concentration of Various Gelling Agents Needed to Maintain Homogeneity of Micronized API in Suspension
Jonathan Behrs
Favorite
Belem, Bruna

University of Sao Paulo
(T1430-03-16) Development of Microemulsion Formulations with D-Limonene and Terbinafine Hydrochloride for Treatment of Cutaneous Fungal Infections
Bruna Belem
Favorite
(W1230-11-60) Development and Validation of Analytical Methodology by Uv-Vis Spectrophotometry for D-Limonene Quantification
Bruna Belem
Favorite
Belhadj, Zakia

University of Minnesota
(W1130-04-19) GSH-Dependent Inhibition of Multidrug Resistance-Associated Protein 1 (MRP1) by ZW-1226
Zakia Belhadj
Favorite
Bellantone, Robert

Physical Pharmaceutica, LLC
(T0930-02-12) A PBPK Model to Simulate Intranasal Naloxone Rescue from Fentanyl Overdose
Robert Bellantone
Favorite
Bembridge, Dawn

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Dawn Bembridge
Favorite
Bendayan, Reina

University of Toronto
(M1530-04-22) Anti-Viral and Anti-Inflammatory Effects of Novel PPARγ Agonist, INT131, in an EcoHIV Mouse Model: Relevance to the Treatment of HIV-Associated Neurocognitive Disorders
Reina Bendayan
Favorite
Bennett, Daniel

Syneos Health
(W0930-06-32) A Sensitive Method for the Detection and Quantitation of Nalmefene in Human Plasma Samples for Pharmacokinetic Analysis
Daniel Bennett
Favorite
Bennette, nathan

Catalent, Inc.
(M1330-10-54) DSC vs. DVS: Determining the Moisture-Induced Tg vs. RH of Hygroscopic Materials
nathan Bennette
Favorite
Bennett-Lenane, Harriet

University College Cork
(T1130-06-33) Investigating the Modelability of Human Oral Fraction Absorbed using Regulatory Data
Harriet Bennett-Lenane
Favorite
Bentley, Elizabeth

University of Pittsburgh
(M1230-07-37) Local Controlled Delivery of an A3 Receptor Agonist Reduces Inflammation Associated with Contact Hypersensitivity
Elizabeth Bentley
Favorite
(T1230-11-60) Characterizing the Effect of Critical Processing Parameters on Critical Quality Attributes of Protein-Loaded Double Emulsion Microparticles
Elizabeth Bentley
Favorite
Bentley, Mackenzie

ICON Plc
(M1430-06-33) The Impact of Unique Stable Label Peptide Internal Standards toward Large Molecule Applications for LC-MS/MS
Mackenzie Bentley
Favorite
Berchielli, Alfred

Pfizer Inc.
(M1530-09-52) Mass Transport Modeling and In Silico Formulation of Osmotic Controlled Release Tablets with Microscopy-Based Digital Twins
Alfred Berchielli
Favorite
(W1130-09-52) Insights in Designing Osmotic Modified Release Delivery Platform for Solid Dispersions: Challenges and Conception
Alfred Berchielli
Favorite
Berezwick, Elizabeth

ARx, LLC
(T1030-09-52) Weekly Apixaban Transdermal Delivery System
Elizabeth Berezwick
Favorite
Berthold, Erin

University of Florida
(M1330-02-09) Translational Pharmacokinetic Assessment of Mitragyna Speciosa (kratom), a Potential Treatment Option for Opioid Use Disorder
Erin Berthold
Favorite
Bertrand, Holly

International Flavors and Fragrances
(M1430-01-04) Formulation and In Vitro Evaluation of Carrageenan Based Gummies
Holly Bertrand
Favorite
Betram, Lee

Agilent Technologies, Inc
(M1430-06-31) A Sensitive Bioanalysis Method for Antisense Oligonucleotides using LC-MS/MS
Lee Betram
Favorite
Bettencourt, Brian

Torque Bio
(M1130-06-31) Phenyl SPE: A Promising Alternative to More Common Oligonucleotide Extraction
Brian Bettencourt
Favorite
Bhagali, Vedant

Seran Bioscience, LLC
(W0930-05-30) Broad Applicability of a Model for Predicting Tabletability of Mixtures from Those of Individual Components
Vedant Bhagali
Favorite
Bhalkikar, Anuja

Sciex
(T1530-10-54) High-Speed Compound Quality Assessment Using Acoustic Ejection Mass Spectrometry
Anuja Bhalkikar
Favorite
Bhalla, Aanya

University of Texas at Austin
(T1330-09-49) In Vivo and Biopredictive In Vitro Dissolution Testing of Dexamethasone Intravitreal Implants in Rabbits
Aanya Bhalla
Favorite
Bhalla, Amardeep

Regeneron Pharmaceuticals
(M1030-11-64) Thaw Time Prediction for Partially-Filled Bottles of Antibody Solution in Varying Environments – Predictive Statistical Model on CFD-Generated Datasets
Amardeep Bhalla
Favorite
(T1430-03-15) FluoriPack Technology: A Non-aqueous Emulsification Process to Develop Polymeric Microspheres for Sustained Delivery of Biologics
Amardeep Bhalla
Favorite
Bhat, Divya

University of Iowa
(W1130-04-21) Identification of Potential Drug Combinations against BRAF V600E,p53 R273H HT-29 Colon Cancer Cells With and Without BRCA1 Knocked Down
Divya Bhat
Favorite
Bhat, Roopal

New Jersey Institute of Technology
(M1430-11-65) Particle Engineering Approach to Formulating Hot Melt Extrusion Amorphous Solid Dispersion Tablets
Roopal Bhat
Favorite
Bhattarai, Nirajan

Idaho State University
(W1230-04-19) Explainable Artificial Intelligence (XAI) for Generation of Library of Novel Potential Acetylcholinesterase Inhibitors
Nirajan Bhattarai
Favorite
Bhattarai, Prapanna

Texas A&M University
(T0930-01-03) Intracellular Drug Delivery by Discrete Multiwalled Carbon Nanotubes for MDR Cancer Treatment
Prapanna Bhattarai
Favorite
Bhattarakosol, Parvapan

Chulalongkorn University
(M1130-01-04) Utilizing Hydroxypropyl Methylcellulose (HPMC) and Carrageenan in Nasal Spray Gel with Andrographis paniculata Extract for COVID-19 Prevention
Parvapan Bhattarakosol
Favorite
Bhongade, Yogeshwary

Rashtrasant Tukadoji Maharaj Nagpur University
(M1030-01-05) Novel Combination Approach to Enhance Solubility and Permeability of Pazopanib Using Phospholipid Complex and a Bioenhancer
Yogeshwary Bhongade
Favorite
Bhoopathy, Siddhartha

Pharmaron (Exton) Lab Services LLC
(T1030-02-08) The Potential of In Vitro Dissolution Absorption System 2 (IDAS2) as a Bioequivalence Decision Tool
Siddhartha Bhoopathy
Favorite
Bhorkade, Saurabh

University of Connecticut
(T1230-05-27) Impact of Polymer Residual Content on the Quality Characteristics of Risperidone PLGA Microspheres
Saurabh Bhorkade
Favorite
Bhosale, Devyani

Bristol-Myers Squibb Company
(T0930-06-31) Non-Tissue Based Screening Methods for Selection of Immunohistochemistry Antibody Candidates
Devyani Bhosale
Favorite
Bhusane, Nitin

Shin-Etsu Chemical Tylose India Pvt., Ltd.
(M1030-10-58) A Comparative Study of Hypromellose Acetate Succinate and HPMCP by Spray Drying Method and Top Spray Method for Solubility Enhancement
Nitin Bhusane
Favorite
(M1130-07-39) Revolutionizing Drug Formulations: Delayed Release and Sustained Release Using Hypromellose 2208 Types and Hypromellose Acetate Succinate
Nitin Bhusane
Favorite
Bianchet-David, Samuele

Moderna, Inc.
(M0930-02-10) Multiplexed Cytokine Measurements in Culture Supernatants upon Ex Vivo Stimulation of Human PBMCs to Assess Cellular Immune Response in Vaccine Studies
Samuele Bianchet-David
Favorite
Bielski, Elizabeth

US Food and Drug Administration
(T0930-09-51) Enhanced PBPK-Based In Vitro to In Vivo Extrapolation Method to Support the Development of Pulmonary Drug Products
Elizabeth Bielski
Favorite
Bigos, Pawel

Waters Corporation
(W1030-10-58) Next-Generation Bio-Inert HPLC System for Enhanced Analysis of Biotherapeutics
Pawel Bigos
Favorite
Bilchak, Connor

BASF Corporation
(M1130-05-29) Rapid Detection of Formulation Stability for Fast Product Development
Connor Bilchak
Favorite
(T1130-09-53) Smart Formulating of Pharmaceutical Emulsions Using HLD-NAC Theory
Connor Bilchak
Favorite
Billa Nys, Cecile

MaaT Pharma
(W0930-01-05) Oral Targeting of Sensitive Microbiome: A Case from Development of Functional Coated Capsule to Clinical Trial Phase 1b
Cecile Billa Nys
Favorite
Billa, Nashiru

Qatar University
(M1330-01-01) The Anti-Colon Cancer Potential of Succinylated Curcumin Encapsulated in Mannosylated Chitosan
Nashiru Billa
Favorite
Bing, Tiejun

ICE Bioscience
(M1030-04-19) Integrated Screening Platform of PDE for Lung Fibrosis Drug Discovery
Tiejun Bing
Favorite
(T1030-04-21) A PARPi Screening Cascade to Facilitate Novel Drug Discovery
Tiejun Bing
Favorite
Binzet, Gulsilan

UNM College of Pharmacy
(M1330-10-57) Enhancing Tablet Manufacturing Flexibility: Design Space Determination with Compaction Simulator
Gulsilan Binzet
Favorite
Birdsall, Robert

Waters Corporation
(T1430-05-26) Lipid Nanoparticle Impurity Analysis: Leveraging Mass Spectrometry to Monitor Impurities and Aldehyde in Raw Materials and Formulated Drugs in Regulated Environments
Robert Birdsall
Favorite
(W1030-10-58) Next-Generation Bio-Inert HPLC System for Enhanced Analysis of Biotherapeutics
Robert Birdsall
Favorite
Birkmire, Andrew

GEA Process Engineering, Inc.
(T1330-09-51) Klucel Fusion™ HPC Facilitating Continuous Melt Granulation in a GEA ConsiGma® Granulator
Andrew Birkmire
Favorite
Birnbaum, Angela

University of Minnesota
(T1530-02-11) Prediction of Lacosamide Concentrations to Optimize Dosing during Pregnancy
Angela Birnbaum
Favorite
Bishop, Hannah

International Flavors and Fragrances
(T1030-01-01) Vegetarian Softgels Using SeaGel® Technology for Pharmaceutical Applications
Hannah Bishop
Favorite
(W1230-03-14) Impact of Lubricant on Functional Tablet Coatings Containing Pectin
Hannah Bishop
Favorite
Bis, Joanna

Alcami Corporation
(M1230-04-19) Guaifenesin: Discovery and Attributes of Novel Racemic Compound
Joanna Bis
Favorite
(W0930-11-62) Quantification of Novel Racemic Compound of Guaifenesin in Commercial Conglomerate Material Using Powder X-ray Diffraction
Joanna Bis
Favorite
Bist, Ganesh

State University of New York
(M1230-06-32) Identification of Small Molecule APJ Receptor Antagonists for Treatment of Cancers
Ganesh Bist
Favorite
Blakely, Kyle

Eli Lilly and Company
(M0930-01-06) Implementing Co-processed API to Enable High-Drug-Load Formulation for Direct Compression
Kyle Blakely
Favorite
Blanco, Marco

Merck & Co., Inc.
(T1130-03-16) Rational Design of Viscosity-Reducing Formulation Compositions for High-Concentration Protein Solutions
Marco Blanco
Favorite
Blass, Benjamin

Temple University
(M1430-03-14) Intravitreal Delivery of Anti-Inflammatory Agents via Thermo-Responsive Gel-Forming Biodegradable Triblock Copolymers
Benjamin Blass
Favorite
(T1330-01-01) Use of Thermo-Responsive Biodegradable Triblock Copolymers in Design of a Novel Delivery Formulation for Intravitreal Injection of Pirfenidone
Benjamin Blass
Favorite
Blattner, simone

Boehringer Ingelheim
(M1330-09-50) Bioequivalence Prediction with Dissolution-Permeation Set Up and tinyTim for Amorphous Solid Dispersion Manufactured by a Novel Co-precipitation Process and Spray Drying
simone Blattner
Favorite
Boateng, Morrison

Roquette America Inc.
(M1530-07-40) Mannitol vs Lactose in Twin Screw Continuous Wet Granulation Using New Binder
Morrison Boateng
Favorite
Bobbala, Sharan

West Virginia University
(M1530-09-48) Dual Adjuvanted Ionizable Lipid Nanoparticles for Vaccine Delivery
Sharan Bobbala
Favorite
Boc, Susan

US Food and Drug Administration
(T0930-09-51) Enhanced PBPK-Based In Vitro to In Vivo Extrapolation Method to Support the Development of Pulmonary Drug Products
Susan Boc
Favorite
Bodycomb, Jeffrey

Horiba
(M1030-11-62) Orthogonal Measurement of Number Concentration Standards for NTA Calibration
Jeffrey Bodycomb
Favorite
Bogdanowich-Knipp, Susan

Improved Pharma
(M1230-11-62) Physical Stability of Ritonavir Crystallized in Space
Susan Bogdanowich-Knipp
Favorite
(T1230-11-62) Chemical Stability of Ritonavir Crystallized in Space
Susan Bogdanowich-Knipp
Favorite
(W1030-11-61) Sending Ritonavir to Space and Back – Drug Development Enabled by Specially Designed Hardware to Perform in Microgravity
Susan Bogdanowich-Knipp
Favorite
Bogner, Robin

University of Connecticut
(T1030-03-17) Lyoprotectants Affecting Product Stability of Lyophilized mRNA-Lipid Nanoparticles
Robin Bogner
Favorite
Bohack, Leigh

Pfizer Inc.
(T1130-03-18) Leveraging Prior Knowledge for Drug Product Development: A Streamlined Lab-Scale Process Characterization Study Approach
Leigh Bohack
Favorite
Boini, Krishna M.

University of Houston
(T1130-04-19) Thioredoxin Interacting Protein (TXNIP) Inhibitor Protects Against Nicotine-Induced Podocyte Injury and Glomerular Sclerosis
Krishna M. Boini
Favorite
(T1130-04-22) Membrane Raft Redox Signalling Pathway Mediates Gut Microbial Metabolite TMAO-Induced NLRP3 Inflammasome Activation and Endothelial Dysfunction
Krishna M. Boini
Favorite
Boirie, Breana

Florida A&M University
(T1130-02-11) Cannabinoid Combination Therapy for Doxorubicin Resistant MDA-MB231: Oral Exosome Formulation Versus Parenteral Approaches
Breana Boirie
Favorite
Bois, Frederic

Certara UK Ltd
(M1030-02-08) Mechanistic Mathematical Modeling of In Vitro Drug Release from PLGA-Based Dexamethasone Solid Implants
Frederic Bois
Favorite
(T1230-02-08) Physiologically Based Pharmacokinetic Modelling of Risperidone and Its Metabolite Paliperidone PLGA Based In Situ Gel Forming Long-Acting Injectable Formulations In Vivo
Frederic Bois
Favorite
Bokharaei, Mehrdad

Evonik Canada, Inc.
(M0930-09-51) Improvements in Liposomal Manufacturing Technology
Mehrdad Bokharaei
Favorite
Bokma, Evert

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Evert Bokma
Favorite
Bolger, Michael

University of Southern California
(M1030-04-20) A Physiologically Based Pharmacokinetic Model of ¹⁸F-FMAU to Accompany Positron Emission Tomography in Humans
Michael Bolger
Favorite
Bollini, Stephanie

Pfizer Inc.
(T1230-10-58) Evaluation of Mitigation Approaches for Nitrosamine Formation in Binary Blends
Stephanie Bollini
Favorite
Bong, Yong-Sik

RNAimmune Inc
(T1230-06-36) Quantitative Assessment of mRNA Drug Biological Activity by Cell-Based Assays
Yong-Sik Bong
Favorite
Bonnaire, Thierry

Population Council
(T0930-05-26) On-Demand Multi-Indication Fast-Disintegrating Tablets for HIV Prevention and Birth Control: Formulation Development and In Vitro Evaluation
Thierry Bonnaire
Favorite
Bonnel, David

Aliri Bioanalysis
(M0930-06-32) Development of Quantitative MALDI Mass Spectrometry Imaging Methods for Studying Distribution of Antituberculosis Drugs at Their Site of Action
David Bonnel
Favorite
(M1330-06-32) Quantifying and Mapping ATP Distribution Within Tissues to Inform Targeted Therapeutic Strategies in Drug Development
David Bonnel
Favorite
(T1330-01-05) Exploring the Spatial Distribution of mRNA-Lipid Nanoparticles in Mouse Whole-Body and Isolated Organs Using MALDI MSI
David Bonnel
Favorite
(W1030-02-08) Distribution of Standard-of-Care Antituberculosis Drugs in Cynomolgus Macaque Lungs
David Bonnel
Favorite
Bonon, Anderson

Horiba
(M1030-11-62) Orthogonal Measurement of Number Concentration Standards for NTA Calibration
Anderson Bonon
Favorite
Bookwala, Mustafa

Merck & Co., Inc.
(W0930-03-17) Molecular Structure-Based Predictions of Amorphous Solid Dispersion Formation Are More Accurate When Appropriate Solvent and Faster Solidification Kinetics Are Used
Mustafa Bookwala
Favorite
Boonyasuppayakorn, Siwaporn

Chulalongkorn University
(M1130-01-04) Utilizing Hydroxypropyl Methylcellulose (HPMC) and Carrageenan in Nasal Spray Gel with Andrographis paniculata Extract for COVID-19 Prevention
Siwaporn Boonyasuppayakorn
Favorite
Borbridge, Lisa

AbbVie Inc.
(T1230-06-33) Development and Validation of LC-MS/MS Assay Methods to Determine Ubrogepant and Atogepant in Human Breast Milk
Lisa Borbridge
Favorite
Borrelli, Matthew

University of Pittsburgh
(M1230-06-31) Manipulating the PLGA Terminal Group Chemistry Alters Electrostatic Controlled Release from Polymeric Microparticles
Matthew Borrelli
Favorite
Bortolotti, Fabrizio

University of Ferrara
(M1330-01-06) Formulation of a Poorly Soluble Antiviral Drug as Microparticle Powder for Nasal Breath Intake Against Respiratory Infections
Fabrizio Bortolotti
Favorite
Borza, Chloe

GEA Process Engineering, Inc.
(T1330-09-51) Klucel Fusion™ HPC Facilitating Continuous Melt Granulation in a GEA ConsiGma® Granulator
Chloe Borza
Favorite
Bosco, Geoffrey

Thermo Fisher Scientific
(T1530-11-64) A Rational Approach to Scaling-Up Lubrication in Pharmaceutical Tablet Manufacturing
Geoffrey Bosco
Favorite
Bose, Neelanjan

Emery Pharma
(T1330-06-34) LC-MS/MS Method for the Quantitation of Each Monoclonal Antibody (from a 6-Components Antibody Cocktail Drug Product) in Human Serum Matrix
Neelanjan Bose
Favorite
(W0930-06-36) ICH M10 Bioanalytical Method Validation for Quantitation of Ketorolac in Human Vitreous and Aqueous Humor using Human Plasma as a Surrogate Matrix
Neelanjan Bose
Favorite
Botoy, Teslin

Ashland Specialty Ingredients
(M1230-09-48) Role of Low Nitrite (LN) Excipients in Mitigating N-Nitrosamine Drug Substance-Related Impurity (NDSRI) Formation in Drug Products
Teslin Botoy
Favorite
Böttger, Roland

CureVac
(T1030-10-57) Dry Powders of a Rabies G Protein mRNA Vaccine Candidate Prepared by Thin-Film Freeze-Drying
Roland Böttger
Favorite
(T1430-03-14) Delivery of mRNA-LNP Vaccine via Refrigerator-Stable Microneedle Array Patch
Roland Böttger
Favorite
Bouchard, Beth

Prolytix
(T1130-11-64) Successful Validation of a Thrombin Generation Assay (TGA) for the Release of an Intravenous Immunoglobulin (IVIG) Drug
Beth Bouchard
Favorite
Boulet, Pascal

Institut Jean Lamour
(T1330-07-39) Hot Melt Extruded Amorphous Solid Dispersions Containing Lumefantrine and Soluplus
Pascal Boulet
Favorite
Bourcy, Quentin

University of Liege
(M1230-02-08) In Vitro – In Vivo Correlation Studies of Amorphous and Lipid-Based Oral Cannabidiol Formulations
Quentin Bourcy
Favorite
Boute, Melodie

Aliri Bioanalysis
(M1430-02-12) Integrating Omics Data Through AI: Predicting Novel Therapeutic Targets for Therapy-Resistant Cancer Patients
Melodie Boute
Favorite
(T1030-02-12) Elucidating the Role of IL-8 in NSCLC: Integrated Analysis Through Imaging Mass Cytometry, Mass Cytometry, and Single-Cell Sequencing
Melodie Boute
Favorite
Boxer, Matt

Veralox Therapeutics, Inc.
(W0930-02-11) VLX-1005 Multiple Ascending Dose Pharmacokinetics
Matt Boxer
Favorite
Boyce, Heather

US Food and Drug Administration
(M1530-02-07) Evaluation of the Pharmacokinetics and Abuse Potential of Intranasally Administered Extended-Release Oxycodone and Naloxone Abuse-Deterrent Formulations Milled to Different Particle Sizes
Heather Boyce
Favorite
(W1230-07-38) Ethanol Solubility of Rate Controlling Polymer in Modified Release Formulation Can Impact Alcohol Dose Dumping: An Assessment Through Principal Component Analysis
Heather Boyce
Favorite
Braddy, April

US Food and Drug Administration
(M1030-06-32) Analytical Considerations of Drug Products Containing Isomeric Active Pharmaceutical Ingredients in Abbreviated New Drug Application (ANDA) Submissions
April Braddy
Favorite
(M1030-06-34) In Vitro Permeation Test Outlier Data Evaluation during Bioequivalence Assessment of Abbreviated New Drug Applications
April Braddy
Favorite
(M1430-02-11) Common Bioequivalence (BE) Deficiencies Identified in ANDAs Associated with Solid Oral Extended-Release Drugs in Various Therapeutic Areas: A Retrospective Survey of BE Study Data Submitted to the FDA
April Braddy
Favorite
(M1430-06-35) Avoiding Pitfalls in Selecting Quality Control Concentrations in Surrogate Matrix Approach for Endogenous Drugs
April Braddy
Favorite
(T0930-10-56) Current Drug Substance Stability Issues Related to the Biopharmaceutics Classification System (BCS) Class III -Based Biowaivers in Abbreviated New Drug Applications (ANDAs)
April Braddy
Favorite
(T1430-02-09) Evaluation of Methods for Assessing Pre-Dose Steady-State Drug Concentration Attainment in Bioequivalence Studies in Abbreviated New Drug Application (ANDA) Submissions
April Braddy
Favorite
Bradley, Logan

Mount St. Joseph University
(M0930-07-40) Application of Binder Jetting to Develop 3D Printed Modified Release Tablets
Logan Bradley
Favorite
Braithwaite, Christian

BioAgilytix
(T0930-06-34) Assessing Parallelism of IFN-beta and IL-29 in Human K2EDTA Plasma Post Stimulation with LPS and PHA
Christian Braithwaite
Favorite
Brandl, Ferdinand

BASF Corporation
(T1530-09-52) Leveraging an Algorithm-Based Digital Platform for Excipient selection facilitating Formulation Development of Poorly Soluble Active Pharmaceutical Ingredients
Ferdinand Brandl
Favorite
Brantley, Scott

BioCryst Pharmaceuticals, Inc.
(M1230-02-10) No Clinically Meaningful Pharmacokinetic Drug-Drug Interaction Between Berotralstat and the Progestin Oral Contraceptive Desogestrel
Scott Brantley
Favorite
Braun, michael

Boehringer-ingelheim
(M1330-09-50) Bioequivalence Prediction with Dissolution-Permeation Set Up and tinyTim for Amorphous Solid Dispersion Manufactured by a Novel Co-precipitation Process and Spray Drying
michael Braun
Favorite
Breitkreutz, Joerg

Heinrich Heine University Duesseldorf
(M1030-03-15) Formulation-Related Influences on the Ex Vivo Permeation of Lidocaine Hydrochloride Films
Joerg Breitkreutz
Favorite
(M1230-11-63) Prediction Model for the Dry Film Thickness in the Continuous Manufacturing of Oral Films
Joerg Breitkreutz
Favorite
Brewer, Edward

Aliri Bioanalysis
(W0930-06-34) Validation of an LCMS Hybrid Assay with EVOSEP Cleanup for the Quantitation of Islet Amyloid Polypeptide in Human Plasma
Edward Brewer
Favorite
Breydo, Leonid

Regeneron Pharmaceuticals
(M1130-05-27) Evaluating the Efficacy of Polyoxyethylene Sorbitan as a Novel Surfactant in Biotherapeutic Antibody Formulations
Leonid Breydo
Favorite
Bridges, Riley

Dow Development Laboratories, LLC
(W1030-07-40) Using Gravitational Force to Determine the Minimum Concentration of Various Gelling Agents Needed to Maintain Homogeneity of Micronized API in Suspension
Riley Bridges
Favorite
Brishti, Masuma Akter

University of Tennessee Health Sciences Center
(M1530-06-31) Insulin Resistance Triggers Histamine Release from Endothelial Cells Which Disrupts Endothelial Barrier Function and Causes Vasoconstriction
Masuma Akter Brishti
Favorite
Brogden, Nicole

University of Iowa
(M1230-09-49) Microneedle-Based Co-Delivery System for Naproxen Sodium and Caffeine in Migraine Therapy
Nicole Brogden
Favorite
Broocks, Stefanie

University of Greifswald
(W1030-05-30) One Like the Other? A Novel In Vitro Release Method to Ensure Proper Drug Release of Extended-Release Mini-Tablets for Paediatric Use
Stefanie Broocks
Favorite
Brooks, Ashley

Fortrea Clinical Research Unit Ltd
(M0930-10-57) Open Label, Single Center, 2 Part Parallel Study to Determine the Absolute Bioavailability and the Absorption, Metabolism, and Elimination Properties of [¹⁴C]E7386 in Healthy Male Subjects
Ashley Brooks
Favorite
Brooks, Catherine

Lovelace Biomedical Research Institute
(T1430-06-35) Comparative Analysis of High-Throughput RNA Extraction Kits in Naïve Non-Human Primate Tissues for Downstream Applications Utilizing Xeno Internal Positive Control (IPC)
Catherine Brooks
Favorite
Brown, David

RNAimmune Inc
(T1230-06-36) Quantitative Assessment of mRNA Drug Biological Activity by Cell-Based Assays
David Brown
Favorite
Brown, Dustin

US Food and Drug Administration
(W1030-10-56) Validation and Application of an LC-MS/MS Method to Evaluate In Vitro Permeation of Naloxone Nasal Spray Using Artificial Substrate
Dustin Brown
Favorite
Brown, Jason

Adare Pharmaceuticals, Inc.
(T1330-11-62) Laboratory Study in Gastric Nitrosamine Formation
Jason Brown
Favorite
(W1030-01-01) Nitrosamine Mitigation Case Study: The Importance of Utilizing a Multi-Pronged Approach to Reduce Impurities
Jason Brown
Favorite
Brown, Rayven

Meso Scale Discovery
(W1230-02-08) Multiplexed Assays for Detection of IgG Antibodies against AAV Serotypes
Rayven Brown
Favorite
Brumm, Jochen

Genentech, Inc
(M1130-02-10) Bivariate Statistical Analyses Reveal the Performance of Human FcRn Transgenic Mouse in Predicting Human Pharmacokinetics of Therapeutic Antibodies
Jochen Brumm
Favorite
Brunaugh, Ashlee

University of Michigan
(W1030-04-22) Antimicrobial Effects of S-nitrosothiols on Mycobacterium abscessus Biofilms
Ashlee Brunaugh
Favorite
Bryniarski, Mark

Amgen Inc.
(M0930-10-58) Protein Engineering Strategies to Overcome High Target-Independent Clearance of Monoclonal Antibodies Due to Charge-Driven Liabilities
Mark Bryniarski
Favorite
Buchholtz, Bruce

Lawrence Livermore National Laboratory
(T1130-11-63) Optical Radiocarbon (¹⁴C) Tracing for Biological and Pharmaceutical Applications
Bruce Buchholtz
Favorite
Buchholz, Bruce

Lawrence Livermore National Laboratory
(M0930-06-31) Parallel Accelerator and Molecular Mass Spectrometry for Tracing ¹⁴C-Labeled Metabolites
Bruce Buchholz
Favorite
Buckner, Ira

Duquesne University
(T1330-05-29) Selection of Excipients for Levodopa-Loaded Microparticles Prepared Using Spray-Drying
Ira Buckner
Favorite
(W0930-03-17) Molecular Structure-Based Predictions of Amorphous Solid Dispersion Formation Are More Accurate When Appropriate Solvent and Faster Solidification Kinetics Are Used
Ira Buckner
Favorite
Bunce, Campbell

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Campbell Bunce
Favorite
(W1230-02-07) EpiScreen®2.0 Time Course Assay: A Sensitive and Data Rich Tool for Pre-Clinical Immunogenicity Testing of Biologics
Campbell Bunce
Favorite
Bunce, Lucy

Waters Corporation
(M1430-11-64) System Robustness and Best Practices of a High Throughput LC-MS Method for Cell Culture Media Nutrient and Metabolite Analysis
Lucy Bunce
Favorite
Burgess, Diane

University of Connecticut
(M1130-04-20) Impact of Macrophages on the Dissolution of Long-Acting Injectable Suspensions
Diane Burgess
Favorite
(T1230-05-27) Impact of Polymer Residual Content on the Quality Characteristics of Risperidone PLGA Microspheres
Diane Burgess
Favorite
(T1530-09-49) Untangling the Interplay of Drug Solubility, Microstructure, and Polymer Behavior on the Performance of Commercial Controlled Release Microsphere Products
Diane Burgess
Favorite
Burgess, Diane

University of Connecicut
(W0930-09-52) Uncovering the Role of Risperidone Attributes on the In Vitro Release and Formation of In Situ Forming Implants
Diane Burgess
Favorite
Burke, Erin

Univar Solutions
(M1230-07-38) Improved Ibuprofen Tablet Formulation Using Co-Processed Excipients Containing Polyethylene Glycol 8000
Erin Burke
Favorite
Burns, Sarah

University of Florida
(T1130-06-36) Synthesis and Biological Evaluation of Dual Acting Sigma Receptor Ligands and Dopamine Transporter Ligands as Potential Treatment Cocaine Misuse
Sarah Burns
Favorite
Burton, Shawn

Aliri Bioanalysis
(M1330-02-10) Development of a Mitra Tip Extraction Assay Coupled with LC-MS/MS for Quantitation of L-Citrulline, L-Arginine, and L-Argininosuccinic Acid: A Novel Approach for Biomarker Analysis
Shawn Burton
Favorite
Bush, Xin

US Food and Drug Administration
(T0930-11-64) Evaluation of CQA Outcomes in Cell Line Changes in Upstream Biomanufacturing
Xin Bush
Favorite
Butikofer, Sydney

Eli Lilly and Company
(T1030-11-65) Formulation in a Droplet – a Material Sparing Approach to Wet Granulation Formulation Screening
Sydney Butikofer
Favorite
(T1530-11-65) Developing a Spray Flux Equation for a Semi-Continuous Fluid Bed Granulation System
Sydney Butikofer
Favorite
Butler, Phil

BASF Corporation
(W1130-11-63) A New Shear Protectant: Introducing Kolliphor^® P188 Cell Culture
Phil Butler
Favorite
Butterworth, Sara

Rayner Surgical
(W0930-06-36) ICH M10 Bioanalytical Method Validation for Quantitation of Ketorolac in Human Vitreous and Aqueous Humor using Human Plasma as a Surrogate Matrix
Sara Butterworth
Favorite
Bu, Yingzi

University of Michigan
(T1130-06-35) Leveraging Machine Learning to Predict Clinical Adverse Events Driven by Target-Specific and Off-Target Binding
Yingzi Bu
Favorite
Byrn, Stephen

Purdue University
(M1230-11-62) Physical Stability of Ritonavir Crystallized in Space
Stephen Byrn
Favorite
(T1230-11-62) Chemical Stability of Ritonavir Crystallized in Space
Stephen Byrn
Favorite
(T1530-09-48) Copovidone-Based Spray Dried Amorphous Solid Dispersions: Investigation of Drug Loadings and the Limit of Congruency
Stephen Byrn
Favorite
(W0930-11-64) Developing an Assessment Framework, Items, and Expert Reviews for an Educational Instrument for the Proper Use of the USP/NF Pharmacopeia
Stephen Byrn
Favorite
(W1030-11-61) Sending Ritonavir to Space and Back – Drug Development Enabled by Specially Designed Hardware to Perform in Microgravity
Stephen Byrn
Favorite
Byun, Sanghwan

Korea University
(M1330-11-62) Simultaneous Detection of Camostat/Niclosamide Cocrystal and Its Related Impurities via Analytical Quality by Design
Sanghwan Byun
Favorite